Anchor Capital Advisors LLC Sells 26,567 Shares of Corteva, Inc. $CTVA

Anchor Capital Advisors LLC trimmed its position in shares of Corteva, Inc. (NYSE:CTVA) by 4.0% during the 4th quarter, Holdings Channel reports. The fund owned 637,237 shares of the company’s stock after selling 26,567 shares during the period. Anchor Capital Advisors LLC’s holdings in Corteva were worth $42,714,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC increased its position in Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the last quarter. Woodline Partners LP lifted its position in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC grew its stake in shares of Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in shares of Corteva in the 2nd quarter worth about $1,464,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance

CTVA stock opened at $77.50 on Wednesday. The stock has a market cap of $51.83 billion, a PE ratio of 45.59, a P/E/G ratio of 2.38 and a beta of 0.57. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The company has a 50-day moving average price of $81.32 and a 200 day moving average price of $74.68. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter last year, the firm earned $1.13 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. The Goldman Sachs Group upped their target price on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. BNP Paribas Exane boosted their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Oppenheimer upped their price objective on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.